Omead Ostadan
Chief Executive Officer at Cellanome, Inc.
Profile
Presently, Omead Ostadan holds the position of President, Chief Operating Officer & Director at Seer, Inc. (California). In the past he was Senior VP, Chief Product & Marketing Officer at Illumina, Inc. and Vice President-Marketing at Solexa, Inc. (a subsidiary of Illumina, Inc.). Mr. Ostadan received an undergraduate degree from the University of California, Davis and an MBA from The Wharton School of the University of Pennsylvania.
Omead Ostadan active positions
| Companies | Position | Start |
|---|---|---|
Cellanome, Inc.
 Cellanome, Inc. Miscellaneous Commercial ServicesCommercial Services Cellanome, Inc. is a company that specializes in sequencing, microfluidics, and integrated sensors, as well as molecular biology and biochemistry. Cellanome is based in Redwood City, CA. The company has a team of experienced professionals and has partnered with leading life science investors. The CEO of the company is Ali Agah. | Chief Executive Officer | - |
Biomodal Ltd.
 Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 2023-04-12 |
Former positions of Omead Ostadan
| Companies | Position | End |
|---|---|---|
| SEER, INC. | President | 2022-09-29 |
| ILLUMINA, INC. | Chief Operating Officer | 2020-05-31 |
Solexa, Inc.
 Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | Sales & Marketing | 2007-01-25 |
Training of Omead Ostadan
| University of California, Davis | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| SEER, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | Health Technology |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Cellanome, Inc.
Cellanome, Inc. Miscellaneous Commercial ServicesCommercial Services Cellanome, Inc. is a company that specializes in sequencing, microfluidics, and integrated sensors, as well as molecular biology and biochemistry. Cellanome is based in Redwood City, CA. The company has a team of experienced professionals and has partnered with leading life science investors. The CEO of the company is Ali Agah. | Commercial Services |
- Stock Market
- Insiders
- Omead Ostadan
